{ "format" : "linked-data-api", "version" : "0.2", "result" : {"_about" : "http://eldaddp.azurewebsites.net/answeredquestions.text?tablingMember.label=Biography+information+for+Fleur+Anderson&AnsweringBody.=Department+of+Health+and+Social+Care&min-answer.questionFirstAnswered.=2024-04-17T15%3A22%3A42.9Z", "definition" : "http://eldaddp.azurewebsites.net/meta/answeredquestions.text?tablingMember.label=Biography+information+for+Fleur+Anderson&AnsweringBody.=Department+of+Health+and+Social+Care&min-answer.questionFirstAnswered.=2024-04-17T15%3A22%3A42.9Z", "extendedMetadataVersion" : "http://eldaddp.azurewebsites.net/answeredquestions.text?tablingMember.label=Biography+information+for+Fleur+Anderson&AnsweringBody.=Department+of+Health+and+Social+Care&min-answer.questionFirstAnswered.=2024-04-17T15%3A22%3A42.9Z&_metadata=all", "first" : "http://eldaddp.azurewebsites.net/answeredquestions.text?tablingMember.label=Biography+information+for+Fleur+Anderson&_page=0&AnsweringBody.=Department+of+Health+and+Social+Care&min-answer.questionFirstAnswered.=2024-04-17T15%3A22%3A42.9Z", "hasPart" : "http://eldaddp.azurewebsites.net/answeredquestions.text?tablingMember.label=Biography+information+for+Fleur+Anderson&AnsweringBody.=Department+of+Health+and+Social+Care&min-answer.questionFirstAnswered.=2024-04-17T15%3A22%3A42.9Z", "isPartOf" : "http://eldaddp.azurewebsites.net/answeredquestions.text?tablingMember.label=Biography+information+for+Fleur+Anderson&AnsweringBody.=Department+of+Health+and+Social+Care&min-answer.questionFirstAnswered.=2024-04-17T15%3A22%3A42.9Z", "items" : [{"_about" : "http://data.parliament.uk/resources/1718758", "AnsweringBody" : [{"_value" : "Department of Health and Social Care"} ], "answer" : {"_about" : "http://data.parliament.uk/resources/1718758/answer", "answerText" : {"_value" : "

Research is crucial in tackling cancer, which is why the Department invests £1.3 billion per year in health research, through the National Institute for Health and Care Research (NIHR). NIHR research expenditure for all cancers was £121.8 million in 2022/23, and the NIHR spends more on cancer than any other disease group.

The NIHR funded nine research projects on pancreatic cancer since 2018/19, with a committed funding value of £4.3 million. The NIHR continues to welcome funding applications for research into any aspect of human health, including pancreatic cancer. Applications are subject to peer review and judged in open competition.

The NIHR also supports delivery of research into pancreatic cancer in the health and care system, funded by research funding partners in the charity and public sectors. Since 2018/19 the NIHR supported 73 clinical research studies through the Clinical Research Network.

Additionally, NIHR Biomedical Research Centres (BRC) and NIHR Clinical Research Facilities spent a further £6.5 million between 2018/19 and 2022/23, supporting an annual portfolio of approximately 85 early clinical studies into pancreatic cancer. NIHR BRCs are collaborations between world-leading universities and National Health Service organisations, that bring together academics and clinicians to translate discoveries from basic or discovery science into clinical research.

For emotional and financial support, patient feedback is monitored through the National Cancer Patient Experience Survey, with the latest results showing an overall experience of 8.88 out of 10. In areas such as support for health and wellbeing, and information on financial help, results were positive but showed room for improvement. NHS England continues to support trusts to take action to improve cancer patient support.<\/p>"} , "answeringMember" : {"_about" : "http://data.parliament.uk/members/4044", "label" : {"_value" : "Biography information for Andrew Stephenson"} } , "answeringMemberConstituency" : {"_value" : "Pendle"} , "answeringMemberPrinted" : {"_value" : "Andrew Stephenson"} , "dateOfAnswer" : {"_value" : "2024-05-23", "_datatype" : "dateTime"} , "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"} , "questionFirstAnswered" : [{"_value" : "2024-05-23T08:21:01.727Z", "_datatype" : "dateTime"} ]} , "answeringDeptId" : {"_value" : "17"} , "answeringDeptShortName" : {"_value" : "Health and Social Care"} , "answeringDeptSortName" : {"_value" : "Health and Social Care"} , "date" : {"_value" : "2024-05-16", "_datatype" : "dateTime"} , "hansardHeading" : {"_value" : "Pancreatic Cancer: Research"} , "houseId" : {"_value" : "1"} , "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"} } ], "questionText" : "To ask the Secretary of State for Health and Social Care, what steps her Department is taking to help improve (a) research into treatments for and (b) (i) emotional and (ii) financial support for people living with pancreatic cancer.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"} , "tablingMember" : {"_about" : "http://data.parliament.uk/members/4788", "label" : {"_value" : "Biography information for Fleur Anderson"} } , "tablingMemberConstituency" : {"_value" : "Putney"} , "tablingMemberPrinted" : [{"_value" : "Fleur Anderson"} ], "uin" : "26771"} , {"_about" : "http://data.parliament.uk/resources/1718766", "AnsweringBody" : [{"_value" : "Department of Health and Social Care"} ], "answer" : {"_about" : "http://data.parliament.uk/resources/1718766/answer", "answerText" : {"_value" : "

The UK National Screening Committee (UK NSC) currently recommends that all women aged 50 to 71 years old are invited for a breast screening every three years. The AgeX trial is looking at the impact of increasing or decreasing the screening age for breast screening, and the UK NSC will review its findings when they are available.<\/p>

The UK NSC can be alerted to any new published peer reviewed evidence which may suggest the case for a new screening programme, or changes to an existing one. Proposals can be submitted via the UK NSC\u2019s annual call in July 2024, which is available at the following link:<\/p>

https://www.gov.uk/government/publications/uk-nsc-annual-call-submitting-a-screening-proposal/uk-nsc-annual-call-how-to-submit-a-proposal#:~:text=To%20submit%20a%20proposal%20for,your%20name<\/a><\/p>"} , "answeringMember" : {"_about" : "http://data.parliament.uk/members/4044", "label" : {"_value" : "Biography information for Andrew Stephenson"} } , "answeringMemberConstituency" : {"_value" : "Pendle"} , "answeringMemberPrinted" : {"_value" : "Andrew Stephenson"} , "dateOfAnswer" : {"_value" : "2024-05-21", "_datatype" : "dateTime"} , "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"} , "questionFirstAnswered" : [{"_value" : "2024-05-21T16:51:28.003Z", "_datatype" : "dateTime"} ]} , "answeringDeptId" : {"_value" : "17"} , "answeringDeptShortName" : {"_value" : "Health and Social Care"} , "answeringDeptSortName" : {"_value" : "Health and Social Care"} , "date" : {"_value" : "2024-05-16", "_datatype" : "dateTime"} , "hansardHeading" : {"_value" : "Breast Cancer: Screening"} , "houseId" : {"_value" : "1"} , "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"} } ], "questionText" : "To ask the Secretary of State for Health and Social Care, if she will make an assessment of the potential merits of offering breast cancer screening to women going through early menopause.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"} , "tablingMember" : {"_about" : "http://data.parliament.uk/members/4788", "label" : {"_value" : "Biography information for Fleur Anderson"} } , "tablingMemberConstituency" : {"_value" : "Putney"} , "tablingMemberPrinted" : [{"_value" : "Fleur Anderson"} ], "uin" : "26776"} , {"_about" : "http://data.parliament.uk/resources/1713218", "AnsweringBody" : [{"_value" : "Department of Health and Social Care"} ], "answer" : {"_about" : "http://data.parliament.uk/resources/1713218/answer", "answerText" : {"_value" : "

It is the responsibility of local National Health Service commissioners and providers to engage with their stakeholders and make decisions on the provision of services locally to best meet the needs of their patients and population.<\/p>"} , "answeringMember" : {"_about" : "http://data.parliament.uk/members/4527", "label" : {"_value" : "Biography information for Helen Whately"} } , "answeringMemberConstituency" : {"_value" : "Faversham and Mid Kent"} , "answeringMemberPrinted" : {"_value" : "Helen Whately"} , "dateOfAnswer" : {"_value" : "2024-04-29", "_datatype" : "dateTime"} , "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"} , "questionFirstAnswered" : [{"_value" : "2024-04-29T14:31:00.127Z", "_datatype" : "dateTime"} ]} , "answeringDeptId" : {"_value" : "17"} , "answeringDeptShortName" : {"_value" : "Health and Social Care"} , "answeringDeptSortName" : {"_value" : "Health and Social Care"} , "date" : {"_value" : "2024-04-23", "_datatype" : "dateTime"} , "hansardHeading" : {"_value" : "Queen Mary's Hospital Roehampton"} , "houseId" : {"_value" : "1"} , "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"} } ], "questionText" : "To ask the Secretary of State for Health and Social Care, what steps she is taking to ensure the space needed for the Urgent Treatment Centre at Queen Mary\u2019s Hospital in Roehampton be returned to a drop in as well as bookable centre.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"} , "tablingMember" : {"_about" : "http://data.parliament.uk/members/4788", "label" : {"_value" : "Biography information for Fleur Anderson"} } , "tablingMemberConstituency" : {"_value" : "Putney"} , "tablingMemberPrinted" : [{"_value" : "Fleur Anderson"} ], "uin" : "23328"} ], "itemsPerPage" : 10, "page" : 0, "startIndex" : 1, "totalResults" : 3, "type" : ["http://purl.org/linked-data/api/vocab#ListEndpoint", "http://purl.org/linked-data/api/vocab#Page"]} }